These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21972227)

  • 41. Quinacrine revised.
    Zipper J; Dabancens A; Guerrero A; Trujillo V
    Hum Reprod Update; 1995 Jul; 1(4):324-42. PubMed ID: 9080211
    [No Abstract]   [Full Text] [Related]  

  • 42. Recent developments in the implementation of novel designs for early-phase combination studies.
    Wages NA; Conaway MR; Slingluff CL; Williams ME; Portell CA; Hwu P; Petroni GR
    Ann Oncol; 2015 May; 26(5):1036-1037. PubMed ID: 25697216
    [No Abstract]   [Full Text] [Related]  

  • 43. Combining Molecularly Targeted Agents: Is More Always Better?
    Sundar R; Valeri N; Harrington KJ; Yap TA
    Clin Cancer Res; 2017 Mar; 23(5):1123-1125. PubMed ID: 27836864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting tumour metabolism.
    Nat Rev Drug Discov; 2010 Jul; 9(7):503-4. PubMed ID: 20592733
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetics and cancer chemotherapy.
    Workman P; Graham MA
    Eur J Cancer; 1994; 30A(5):706-10. PubMed ID: 8080691
    [No Abstract]   [Full Text] [Related]  

  • 46. Antimutagens and the prevention of chromosomal mutations to drug resistance.
    Hahn FE
    Antibiot Chemother (1971); 1975; 20():112-32. PubMed ID: 773269
    [No Abstract]   [Full Text] [Related]  

  • 47. Metabolic strategies in cancer chemotherapy.
    Weber G
    Biochem Soc Trans; 1990 Feb; 18(1):74-8. PubMed ID: 2185095
    [No Abstract]   [Full Text] [Related]  

  • 48. Norepinephrine may be an underlying factor in chemobrain.
    Fitzgerald PJ
    Int J Cancer; 2021 Jun; 148(12):3119-3120. PubMed ID: 33675534
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings of the Second International Symposium on Improvement of Antitumor Drug Therapeutic Index by Toxicity Reduction. Heidelberg, 6-7 November 1989.
    Cancer Treat Rev; 1990 Sep; 17(2-3):107-378. PubMed ID: 1980232
    [No Abstract]   [Full Text] [Related]  

  • 50. Towards the next generation of antimalaria combination therapies.
    Möhrle JJ
    Lancet Infect Dis; 2021 Dec; 21(12):1620-1621. PubMed ID: 34715033
    [No Abstract]   [Full Text] [Related]  

  • 51. The Antimalaria Campaign.
    Br Med J; 1901 Sep; 2(2123):644-5. PubMed ID: 20759799
    [No Abstract]   [Full Text] [Related]  

  • 52. The Antimalaria Campaign.
    Br Med J; 1902 Dec; 2(2188):1800-1. PubMed ID: 20760567
    [No Abstract]   [Full Text] [Related]  

  • 53. Overcoming cancer therapeutic bottleneck by drug repurposing.
    Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
    Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine.
    Yan H; Bian A; Gao X; Li H; Chen Z; Liu X
    Future Oncol; 2018 Jun; 14(15):1511-1520. PubMed ID: 29380639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphoma researchers in search of molecular targets.
    Friedrich MJ
    J Natl Cancer Inst; 2010 Jul; 102(14):1000-1. PubMed ID: 20616351
    [No Abstract]   [Full Text] [Related]  

  • 56. Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle.
    Das B; Kundu CN
    Anticancer Agents Med Chem; 2021; 21(4):416-427. PubMed ID: 32698746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimalaria drug offers antitumor strategies.
    Hede K
    J Natl Cancer Inst; 2011 Oct; 103(20):1490-1. PubMed ID: 21972227
    [No Abstract]   [Full Text] [Related]  

  • 58. Bypassing phase 1 trials in the cancer drug development paradigm: generally unwise and potentially dangerous.
    Markman M
    Cancer; 2010 Nov; 116(22):5116-8. PubMed ID: 20665504
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.